Leap Therapeutics, Inc. LPTX
0.77 0.00 (+0.00%)
Apr 1, 2026, 9:30 AM EDT
0.7351 Day range 0.7971
52-week range unavailable
- YTD
- -73.28%
- 1 year
- -76.32%
Revenue & Expenses
Latest period ending Dec 31, 2024 · select a line to chart its full history
Income statement
| Fiscal year | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|
| -70.06M | -87.04M | -56.76M | -41.43M | -28.54M | |
| -67.56M | -81.41M | -54.60M | -40.59M | -27.51M | |
| -1.81 | -3.98 | -4.82 | -4.70 | -6.30 |
Balance sheet
| Fiscal year | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|
| 48.07M | 71.61M | 66.61M | 115.21M | 53.05M | |
| 49.12M | 72.83M | 70.35M | 117.91M | 54.37M | |
| 14.08M | 12.68M | 11.49M | 10.02M | 7.72M | |
| 266.00K | 0 | 262.00K | 37.00K | 144.00K | |
| 35.05M | 60.14M | 58.87M | 107.89M | 46.65M |
Cash flow
| Fiscal year | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|
| -60.30M | -43.75M | -49.04M | -35.16M | -25.96M | |
| 37.18M | -30.00K | -210.00K | 98.03M | 74.00M | |
| -23.39M | 5.14M | -49.42M | 62.84M | 48.18M |